Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma

DOI: 10.1080/2162402X.2016.1238542

Keywords: Clear cell carcinoma, cytotoxic T lymphocyte, glypican-3, peptide vaccine, refractory ovarian cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text